ResMed (RMD) reported $1.35 billion in revenue for the quarter ended June 2025, representing a year-over- year increase of 10.2$2.55 for the same period compares to $2.08 a year ago. The reported revenue represents a surprise of +1.87$1.32 billion. With the consensus EPS estimate being $2.46, the EPS surprise was +3.66%. View all Key Company Metrics for ResMed here>>> Shares of ResMed have returned +8.4% over the past month versus the Zacks S&P 500 composite' ...